Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ZYDUS LIFESCIENCES UNICHEM LAB/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 236.1 34.2 689.4% View Chart
P/BV x 1.4 5.8 24.6% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 UNICHEM LAB   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    UNICHEM LAB
Mar-23
ZYDUS LIFESCIENCES
Mar-23
UNICHEM LAB/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs467495 94.4%   
Low Rs226319 70.8%   
Sales per share (Unadj.) Rs190.7170.3 112.0%  
Earnings per share (Unadj.) Rs-28.719.8 -145.2%  
Cash flow per share (Unadj.) Rs-12.626.9 -46.8%  
Dividends per share (Unadj.) Rs06.00 0.0%  
Avg Dividend yield %01.5 0.0%  
Book value per share (Unadj.) Rs344.2173.0 198.9%  
Shares outstanding (eoy) m70.411,012.20 7.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.82.4 76.0%   
Avg P/E ratio x-12.120.6 -58.6%  
P/CF ratio (eoy) x-27.515.1 -181.6%  
Price / Book Value ratio x1.02.4 42.8%  
Dividend payout %030.3 -0.0%   
Avg Mkt Cap Rs m24,396412,144 5.9%   
No. of employees `000NANA-   
Total wages/salary Rs m3,56424,564 14.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m13,430172,374 7.8%  
Other income Rs m3854,746 8.1%   
Total revenues Rs m13,815177,120 7.8%   
Gross profit Rs m-84129,677 -2.8%  
Depreciation Rs m1,1347,227 15.7%   
Interest Rs m1731,299 13.3%   
Profit before tax Rs m-1,76425,897 -6.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2595,878 4.4%   
Profit after tax Rs m-2,02220,019 -10.1%  
Gross profit margin %-6.317.2 -36.4%  
Effective tax rate %-14.722.7 -64.6%   
Net profit margin %-15.111.6 -129.7%  
BALANCE SHEET DATA
Current assets Rs m15,885100,082 15.9%   
Current liabilities Rs m6,39655,267 11.6%   
Net working cap to sales %70.726.0 271.7%  
Current ratio x2.51.8 137.1%  
Inventory Days Days5150 101.8%  
Debtors Days Days1,60094 1,710.5%  
Net fixed assets Rs m15,911144,776 11.0%   
Share capital Rs m1411,012 13.9%   
"Free" reserves Rs m24,092174,146 13.8%   
Net worth Rs m24,233175,158 13.8%   
Long term debt Rs m6360-   
Total assets Rs m31,829244,940 13.0%  
Interest coverage x-9.220.9 -43.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.40.7 60.0%   
Return on assets %-5.88.7 -66.8%  
Return on equity %-8.311.4 -73.0%  
Return on capital %-6.415.5 -41.2%  
Exports to sales %69.739.2 177.9%   
Imports to sales %12.411.9 104.2%   
Exports (fob) Rs m9,36667,577 13.9%   
Imports (cif) Rs m1,66920,544 8.1%   
Fx inflow Rs m9,36667,577 13.9%   
Fx outflow Rs m1,66920,544 8.1%   
Net fx Rs m7,69747,033 16.4%   
CASH FLOW
From Operations Rs m-85126,888 -3.2%  
From Investments Rs m2,02811,712 17.3%  
From Financial Activity Rs m-813-44,004 1.8%  
Net Cashflow Rs m746-5,338 -14.0%  

Share Holding

Indian Promoters % 70.2 75.0 93.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.3 18.0 62.7%  
FIIs % 0.8 5.0 16.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.8 25.0 119.0%  
Shareholders   20,877 306,495 6.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on Unichem Lab vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Unichem Lab vs Cadila Healthcare Share Price Performance

Period Unichem Lab Cadila Healthcare S&P BSE HEALTHCARE
1-Day 1.90% 0.57% 1.18%
1-Month -5.40% 7.77% -0.75%
1-Year 78.12% 107.52% 61.82%
3-Year CAGR 16.06% 32.30% 18.16%
5-Year CAGR 19.87% 24.52% 19.79%

* Compound Annual Growth Rate

Here are more details on the Unichem Lab share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of Unichem Lab hold a 70.2% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Unichem Lab and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, Unichem Lab paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of Unichem Lab, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.